DelveInsight's Botulism Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options. The report also offers comprehensive insights into Botulism market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of market size forward.

Some of the key highlights from the Botulism Market Insights:

• According to the Centers for Disease Control and Prevention (CDC), about 145 cases of botulism are reported every year in the United States. About 3 to 5 percent of those with botulism poisoning die.
• There are three main types of botulism namely infant botulism, foodborne botulism, and wound botulism. In the United States, nearly 65 percent of botulism cases occur in infants or children younger than 1 year of age. Around 15 percent of botulism cases are foodborne.
• The Botulism Therapeutics Market is limited and consists of early phase assets. The key players such as AlphaVax, Merz Therapeutics, Ology Bioservices, DynPort, PanThera Biopharma, and others are involved in the development of therapies for Botulism.
• Some of the key Botulism therapies that are under-development stage include NTM 1631 (formerly known as XOMA 3AB), Biodefence vaccines, Anti-infectives, Botulinum toxin vaccine, and several others. The Botulism therapies are anticipated to launch in the coming years and are expected to improve the treatment outcome for the affected people.
• As per DelveInsight, owing to the R&D activity and the increased incidence, the Botulism Market is expected to grow in the coming years.

Learn more by requesting for sample @ Botulism Market Landscape

Botulism: Overview

Botulism (or botulism poisoning) is a rare but very serious illness caused by a nerve toxin produced by the bacterium Clostridium botulinum. There are three main types of botulism: infant botulism, foodborne botulism, and wound botulism. According to the National Botulism Surveillance Summary (2017), 182 laboratory-confirmed botulism cases were reported to CDC in 2017. The toxin may enter the body depending on the type of exposure. It can transmit through food, contact with contaminated soil, or through an open wound. Botulism is diagnosed based on the clinical history and clinical examination followed by laboratory confirmation. A delay in treatment can lead to paralysis, breathing difficulties, and even death.

For more insights into Disease, causes, and treatment, reach out @ Botulism Treatment Landscape

Botulism Epidemiology Segmentation

The Botulism Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

• Total Incident cases of Botulism
• Cases of Botulism by Toxin Type
• Diagnosed and Treatable cases of Botulism
• Cases of Botulism by transmission category

Visit for more @ Botulism Epidemiological Insights

Botulism Market

The current treatment of Botulism includes Antitoxin which is administered as soon as possible after a clinical diagnosis. Early diagnosis and treatment are effective in reducing mortality rates. Severe botulism cases require supportive treatment, especially mechanical ventilation, which may be required for weeks or even months. In the case of wound botulism, the treatment approach includes antitoxin administration, hospital admission, close monitoring, respiratory support.

The vaccine is available in the market but has some negative side effects. To overcome the existing unmet need and to provide effective therapeutics options, several companies are working to develop new therapies based on different MoA to treat Botulism. Currently, the Botulism therapeutics market is limited and consists of early Phase assets.

Botulism Pipeline Therapies and Key Companies

• NTM 1631 (formerly known as XOMA 3AB) - Ology Bioservices
• Botulinum toxin vaccine - DynPort Vaccine Company LLC
• Biodefence vaccines (Research program) - AlphaVax, Inc.
• Anti-infectives (Research programme) - PanThera Biopharma

For more information, visit: Botulism Market Analysis, Patient Pool, and Emerging Therapies

Botulism Market Drivers

• Rising Incidence
• Launch of the Emerging Therapies
• Ongoing R&D Activities in the Domain

Scope of the Report

• 11 Years Forecast
• 7MM Coverage
• Descriptive overview of Botulism, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
• Comprehensive insight into Botulism epidemiology and treatment in the 7MM
• Current and emerging therapies for Botulism
• Botulism market drivers and barriers

Key Questions Answered in the Report

• What was the Botulism market share (%) distribution in 2017 and how it would look like in 2030?
• What would be the Botulism total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Botulism market size during the forecast period (2017-2030)?
• At what CAGR, the Botulism market is expected to grow in the 7MM during the forecast period (2017-2030)?

Get in touch with our Business executive @ Botulism Market Landscape Analysis

Table of Contents

1

Key Insights

2

Report Introduction

3

Competitive Intelligence Analysis for Botulism

4

Botulism Market Overview at a Glance

5

Executive Summary of Botulism

6

Botulism Epidemiology and Market Methodology

7

Botulism Epidemiology and Patient Population

8

Botulism Patient Journey

9

Treatment Algorithm, Current Treatment, and Medical Practices

10

Key Endpoints in Botulism Clinical Trials

11

Botulism Marketed Therapies

12

Botulism Emerging Therapies

13

Botulism: 7 Major Market Analysis

14

Attribute analysis

15

Access and Reimbursement Overview of Botulism

16

KOL Reviews

17

Case Reports

18

Botulism Market Drivers

19

Botulism Market Barriers

20

SWOT Analysis

21

Disclaimer

22

DelveInsight Capabilities

23

About DelveInsight

Learn more about the report offerings @ Botulism Market Outlook

Related Reports - Botulism Pipeline InsightsBotulism Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Botulism market.

Meniere's Disease MarketDelveInsight's "Meniere's Disease Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Meniere's Disease market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Pars Plantis MarketDelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Pars Plantis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Nicotine Addiction MarketDelveInsight's "Nicotine Addiction Market Insights, Epidemiology and Market Forecast 2030" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Nicotine Addiction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Advanced Wound Care (AWC) MarketDelveInsight's 'Advanced Wound Care (AWC) Market Insights, Competitive Landscape, and Market Forecast-2026' report deliver an in-depth understanding of advanced wound care and the historical and forecasted Advanced Wound Care Market Trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Healthcare Blogs

• Companies in the Peanut Allergy Market
• Transcranial Stimulation Devices Market Growth
• Uncomplicated Urinary Tract Infections Market
• Pharma Companies in Autoimmune Diseases
• Types of Insulin Delivery Devices and Key Companies
• Startups in FemTech Market
• Most Common Skin Cancers
• Cardiac Monitoring Devices Market Size
• JAK inhibitors Portfolio
• Impact of Technological Innovations in Healthcare
• Von Hippel-lindau Pipeline Therapies and Market Trends
• Fecal Incontinence Market Share
• Advancements in Diabetes Treatment and Care
• Major Depressive Disorder Market
• Virtual Clinical Trials Benefits and Challenges
• Technological Innovation in Healthcare
• Leading Medical Drone Delivery Companies
• Duchenne Muscular Dystrophy Clinical Trials
• Key Pharmaceutical Companies in the Venous
• Thromboembolism Market
• Leading Pharmaceutical Companies Worldwide
• Iron Deficiency Anemia Market
• Healthcare Apps Benefits and Disadvantages
• Charcot-Marie-Tooth Disease Therapy Market
• Intratumoral Cancer Therapy Market
• Phenylketonuria Treatment Market
• Systemic Lupus Erythematosus Market

Get in touch with our Business executive for Competitive Intelligence Services

About DelveInsightDelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Tags: Botulism Pipeline, Botulism, Botulism - Market, Botulism Treatment, Botulism Epidemiology, Botulism Therapies

See Campaign: https://www.delveinsight.com/Contact Information:Shruti Thakur info@delveinsight.com +91-9650213330Tags:Menafn, IPS, Reportedtimes, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English